Company / Book Value per Share
Matinas BioPharma Holdings, Inc. Book Value per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$1.747
FY2024
5-year range
$0.169 / $1.747
FY2020-FY2024
Trend
+935.8%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share changed +936% YoY in FY2024, a notable deviation from the 9-year average annual change of +114%.
Based on SEC 10-K filings.
$1.747 in FY2024 with a 5-year CAGR of +65.1%.
Improved from $0.243 to $1.747 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- +88.1%
- 5-Year CAGR
- +65.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +65.1%, indicating consistent growth.
- In FY2024, book value per share increased 935.8% year-over-year.
- Lowest book value per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.747 | +935.8% |
| FY2023 | $0.169 | -30.5% |
| FY2022 | $0.243 | -7.5% |
| FY2021 | $0.262 | -32.8% |
| FY2020 | $0.391 | +174.1% |
| FY2019 | $0.142 | +24.5% |
| FY2018 | $0.114 | -6.9% |
| FY2017 | $0.123 | -1.7% |
| FY2016 | $0.125 | -33.5% |
| FY2015 | $0.188 | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026